Videos
A Case of HR+ Metastatic Breast Cancer
JAK Inhibition for the Management of Primary Myelofibrosis
Primary Myelofibrosis
CLL Case Review: IgHV-Unmutated Therapy Options
David S. Hong, MD, discusses the potential for other TRK inhibitors in the treatment landscape for patients with thyroid cancer after the approval of larotrectinib.
Andre Goy, MD, discusses a few combinations that are being investigated for the treatment of patients with relapsed/refractory mantle cell lymphoma.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Sacituzumab Govitecan: Elevating Quality of Life in First-Line TNBC
2
Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD
3
Dr Mayer on Giredestrant's Success in Early Breast Cancer
4
Breast Cancer Test Using Proteomic Profiling and AI Demonstrates High Performance
5
